Literature DB >> 783196

The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.

J W Smith, B Kaijser.   

Abstract

Although the systemic and local immune response to the O antigen of Escherichia coli has been well characterized, little information is available on the immune response to K anigen. Experimental hematogenous pyelonephritis was produced with Escherichia coli 06 K13 H1 and the serum and local (intrarenal) antibody response to O and K antigens was determined with the enzyme-linked immunosorbent assay. Both local and serum antibody responses to the K antigen were significantly less than that to the O antigen. The K antigen induced low titer IgM and IgG antibody responses in fewer than one-half of the animals and did not induce a local IgA response in any animal. In contrast, the O antigen induced local antibody responses in each of the immunoglobulin classes in all animals from day 9 of infection. Similarly, the serum IgM and IgG antibody titers to the K antigen were significantly less than those evoked in response to the O component of the Escherichia coli. No serum IgA anti-K antibodies were detected. These observations helf clarify the roles of these two antigens in pyelonephritis. Although the K antigen of Escherichia coli functions as a virulence factor in upper urinary tract infections, this antigen does not elicit a significant immune response, whereas the O antigen does induce a significant antibody response which could be of protective or diagnostic benefit.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 783196      PMCID: PMC333180          DOI: 10.1172/JCI108469

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.

Authors:  D L Kasper; J L Winkelhake; W D Zollinger; B L Brandt; M S Artenstein
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

2.  Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.

Authors:  J B Robbins; G H McCracken; E C Gotschlich; F Orskov; I Orskov; L A Hanson
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

3.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  K antigens of Escherichia coli and renal involvement in urinary-tract infections.

Authors:  A A Glynn; W Brumfitt; C J Howard
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

5.  Immunoglobulin synthesis in lower urinary tract infection.

Authors:  W L Hand; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Lab Clin Med       Date:  1970-01

6.  Local antibody production in experimental pyelonephritis: amount, avidity, and immunoglobulin class.

Authors:  J Smith; J Holmgren; S Ahlstedt; L A Hanson
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

7.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. 3. Role of regulatory T cells in the development of an IgG and IgA antibody response.

Authors:  D R Barthold; B Prescott; P W Stashak; D F Amsbaugh; P J Baker
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

8.  Local immune response in experimental pyelonephritis.

Authors:  J D Lehmann; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

9.  Localization and fate of Escherichia coli in hematogenous pyelonephritis.

Authors:  J P SANFORD; B W HUNTER; P DONALDSON
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

10.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  9 in total

1.  Serological response to Escherichia coli pili in pyelonephritis.

Authors:  P Rene; F J Silverblatt
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

2.  Local immune response to Escherichia coli pili in experimental pyelonephritis.

Authors:  J W Smith; S Wagner; R M Swenson
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

3.  Antibody-mediated bacterial adhesion to cytomegalovirus-induced Fc receptors. Potential relationship to secondary infections complicating herpesvirus infections.

Authors:  P A Mackowiak; M Marling-Cason; J W Smith; J P Luby
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.

Authors:  B Kaijser; P Larsson; S Olling
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

5.  Modification by suppressor cells and serum factors of the cell-mediated immune response in experimental pyelonephritis.

Authors:  T Miller; L Scott; E Stewart; D North
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

6.  Sensitive enzyme-linked immunosorbent assay for detection of antibodies against typhus rickettsiae, Rickettsia prowazekii and Rickettsia typhi.

Authors:  S Halle; G A Dasch; E Weiss
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

7.  Local immune response to lipoprotein of the outer membrane of Escherichia coli in experimental pyelonephritis.

Authors:  J W Smith
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

8.  Immune response of the ileum to invasive Escherichia coli diarrheal disease in rabbits.

Authors:  P D O'Hanley; J R Cantey
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Pregnancy bacteriuria and Escherichia coli.

Authors:  I R McFadyen
Journal:  J R Soc Med       Date:  1980-04       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.